December 4, 2023


Virta Health, the leader in type 2 diabetes reversal, earned the Validation Institute’s most prominent, Level 1 savings validation for delivering unmatched medication cost reductions. Per the analysis, Virta’s validated prescription drug savings amounted to nearly $6k per patient over a two-year period.

This press release features multimedia. View the full release here:

As the only vendor in its category to achieve both a cost savings and a health outcomes validation, Validation Institute affirms Virta’s leadership in delivering evidence-based clinical and financial performance. (Graphic: Business Wire)

This validation follows similar findings from a claims-based analysis —with methodology verified by an independent actuarial firm—that showed $10k savings per patient over two years. That report analyzed healthcare utilization in addition to prescription medications. Further, Virta previously received the Validation Institute’s Level 2 certification verifying Virta’s transformative impact on blood sugar control and weight loss, making it the only vendor in its category to achieve both a cost savings and a health outcomes validation.

Combined, these studies reaffirm Virta’s leadership in delivering evidence-based clinical and financial performance.

“In a crowded marketplace, Virta’s innovative diabetes reversal treatment stands out for its proven impact on health outcomes and for driving significant cost savings,” said Benny DiCecca, CEO & President, Validation Institute.

Finding solutions to the diabetes epidemic has never been more critical. The prevalence of diabetes and prediabetes continues to rise, and diabetes-related deaths surged during the pandemic. Meanwhile, payers struggle to manage skyrocketing employee medical costs and insulin prices, while navigating an explosion of digital health vendors with unproven ROI.

Virta offers a clinically and financially validated approach to this crisis. Unlike diabetes management solutions that prioritize medication adherence, Virta’s approach helps patients achieve normal blood sugar while reducing or eliminating diabetes drugs. In Virta’s peer-reviewed evidence, among completing patients at one year, 63% of all diabetes-specific prescriptions are eliminated, and 94% of those using insulin decrease or eliminate their dosage. Patients also see significant improvement in markers of cardiovascular disease and inflammation, and weight loss more than double the FDA benchmark for weight-loss drugs.

To learn more, visit

About Virta Health:

Virta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by nearly 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit or follow us on Twitter @virtahealth.

About Validation Institute:

Validation Institute is an independent, objective, 3rd party organization on a mission to improve the quality and cost of healthcare. Based in Woburn, MA, the organization is made up of a network of health benefits purchasers, health benefits advisors, and healthcare solution providers focused on delivering better health value and stronger outcomes than conventional healthcare.

View source version on

CONTACT: Lauren Cunningham

[email protected]




SOURCE: Virta Health

Copyright Business Wire 2022.

PUB: 04/04/2022 11:27 AM/DISC: 04/04/2022 11:27 AM

Copyright Business Wire 2022.


Leave a Reply

Your email address will not be published. Required fields are marked *